Effectiveness of pharmacotherapy in behavioural therapeutic smoking cessation programmes.

Background: In 2011, pharmacotherapy as a part of smoking cessation treatment was reimbursed through the basic health insurance in the Netherlands. We examine the (cost)-effectiveness of pharmacotherapy added to behavioural therapy.

Methods: An observational study was conducted using data from the suppliers of the smoking cessation programmes together with information on costs from health insurance company Achmea.